Increased Risk of New-Onset Hypertension in Patients With Narcolepsy Initiating Sodium Oxybate: A Real-World Study
In this study, sodium oxybate use was associated with a new-onset hypertension diagnosis or antihypertensive medication initiation in normotensive patients with narcolepsy.
Authors
- Ralph B. D’Agostino (ORCID: https://orcid.org/0000-0002-3550-8395)
- Weiyi Ni (ORCID: https://orcid.org/0000-0003-4244-0699)
- Clark Jackson
- Mat D. Davis
- Wayne Macfadden
- William B. White (ORCID: https://orcid.org/0000-0001-8936-967X)
- Katherine E. Mues
- Virend Kristen Somers (ORCID: https://orcid.org/0000-0003-4045-4341)
- Rami Ben‐Joseph
- Michael N. Cook
- Jed E. Black (ORCID: https://orcid.org/0000-0002-2812-2435)
Institutions
- Jazz Pharmaceuticals (United States) (US)
- Aetion (United States) (US)
- Mayo Clinic in Arizona (US)
- Jazz Pharmaceuticals (Italy) (IT)
- Engineering Information Foundation (US)
- Wake Forest University (US)
- UConn Health (US)
Publication Details
- Journal
- Mayo Clinic Proceedings
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1016/j.mayocp.2024.05.029
- Citations
- 12
- Primary Topic
- Sleep and Wakefulness Research
- Type
- article
- Field-Weighted Citation Impact
- 4.11